chr12-9074723-T-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_ModerateBS2
The ENST00000318602.12(A2M):c.3593A>T(p.Glu1198Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,461,714 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000318602.12 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
A2M | NM_000014.6 | c.3593A>T | p.Glu1198Val | missense_variant | 29/36 | ENST00000318602.12 | NP_000005.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
A2M | ENST00000318602.12 | c.3593A>T | p.Glu1198Val | missense_variant | 29/36 | 1 | NM_000014.6 | ENSP00000323929 | P1 | |
A2M | ENST00000543436.2 | n.452-6911A>T | intron_variant, non_coding_transcript_variant | 5 | ||||||
A2M | ENST00000545828.1 | n.349-2002A>T | intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000797 AC: 2AN: 250962Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135638
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461714Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 727130
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2021 | The c.3593A>T (p.E1198V) alteration is located in exon 29 (coding exon 29) of the A2M gene. This alteration results from a A to T substitution at nucleotide position 3593, causing the glutamic acid (E) at amino acid position 1198 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at